Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays

INTRODUCTION: We evaluated the performance of the new Abbott SARS-CoV-2 IgM assay on the Architect immunoassay analyser and compared it to the Architect IgG/Roche Cobas total antibody assays in both SARS-CoV-2 RT-PCR positive cases and healthy controls. METHOD: 200 healthy control samples and 48 ind...

Descripción completa

Detalles Bibliográficos
Autores principales: CS, Lau, SP, Hoo, YL, Liang, SK, Phua, TC, Aw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079267/
https://www.ncbi.nlm.nih.gov/pubmed/33937471
http://dx.doi.org/10.1016/j.plabm.2021.e00230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079267/
https://www.ncbi.nlm.nih.gov/pubmed/33937471
http://dx.doi.org/10.1016/j.plabm.2021.e00230

Ejemplares similares